Published on 1 Sep 2022 on Bloomberg via Yahoo Finance
Novo Nordisk to Buy Forma Therapeutics in $1.1 Billion Deal
(Bloomberg) -- Novo Nordisk A/S agreed to buy Forma Therapeutics Holdings Inc. in a deal valuing the US biotech company at about $1.1 billion, as it seeks to expand its reach in treatments for rare blood disorders.
Most Read from Bloomberg
Lukoil Chairman Ravil Maganov Dies After Falling From Hospital WindowPutin Brings China and India to Russia for War Games Defying USJeremy Grantham Warns ‘Super Bubble’ in Stocks Has Yet to BurstUS Jobs Data Have Potential to Push Fed Toward Third Jumbo Hike